# DESCRIPTION

## BACKGROUND

- describe gonorrhea and its effects

## SUMMARY

- motivate need for gonorrhea vaccine
- introduce peptide mimics as solution
- describe embodiments of peptide mimics

## DETAILED DESCRIPTION OF CERTAIN EMBODIMENTS

- define acyl
- define alkyl
- define alkenyl
- define antibody and binding affinity
- define heteroalkyl
- define heteroaryl
- define heterocyclyl
- provide examples of heteroaryl groups
- provide examples of heterocyclyl groups
- define linker
- describe characteristics of linker
- define monoclonal antibodies
- define peptide mimic
- define leaving group
- define substituted
- describe R groups
- define protein
- define percent identity
- describe calculation of percent identity
- discuss determination of percent identity using algorithms
- define polymorph and salt
- define subject and treatment

### CERTAIN EMBODIMENTS

- motivate LOS as virulence determinant
- describe limitations of saccharides as vaccine candidates
- introduce peptide mimics as solution
- define peptide mimics and their properties
- describe applications of peptide mimics
- define certain embodiments
- describe peptide mimics coupled to complement protein
- describe peptide mimics coupled to second agent
- describe peptide mimics with carrier protein
- describe formulations for administration
- describe therapeutic applications
- describe kits for modulating immune responses
- provide examples of peptide mimics
- describe importance of complement in host defenses
- describe peptide mimics eliciting immunogenic response
- describe LOS purification
- outline TMCP-2 synthesis
- detail immunization of mice
- explain ELISA to measure anti-LOS antibody levels
- describe inhibition ELISA
- outline depletion of mouse IgM
- detail serum bactericidal assays
- summarize statistical analyses
- describe certain embodiments
- motivate in vitro and in vivo efficacy of TMCP2
- discuss efficacy of TMCP2 using a biweekly schedule
- discuss limitations of previous vaccine candidates
- propose complement-dependent bactericidal antibody activity
- motivate gonococcal vaccine development
- describe LOS biosynthesis and 2C7 epitope
- discuss importance of lgtG expression
- introduce peptide constructs and synthesis approaches
- describe optimization of Tetra-MAP synthesis
- present example of TMCP2 vaccine efficacy

## OTHER EMBODIMENTS

### Embodiment 1

- define compound of Formula (I)

### Embodiment 2

- specify A1, A2, A3, A5, A6, and A7

### Embodiment 3

- specify A1, A2, A3, A5, and A6

### Embodiment 4

- specify A1, A2, A3, A5, and A6 as glycine, proline, or cysteine

### Embodiment 5

- specify A1 as cysteine and A2, A3, A5, and A6 as glycine or proline

### Embodiment 6

- specify A7

### Embodiment 7

- specify A7 as cysteine, substituted or unsubstituted acyl, or substituted or unsubstituted alkylene

### Embodiment 8

- specify A7 as —(C═X)—CR2—

### Embodiment 9

- specify A7 as *—(C═O)—CH2—
- specify A4 as antigenic peptidyl sequence
- specify A4 as 12-mer antigenic peptidyl sequence
- specify A4 as 12-mer antigenic peptidyl sequence with specific amino acid residues
- specify A4 as *-Ile-Pro-Val-Leu-Asp-Glu-Asn-Gly-Leu-Phe-Ala-Pro

